Skip to main content
. 2017 Sep 7;7:10811. doi: 10.1038/s41598-017-11321-x

Table 3.

Comparison of characteristics and examination findings with and without hepatotoxicity.

hepatotoxicity no hepatotoxicity p-value
Number of patients 16 52
Age 75.0 (68.8–76.3) 72.0 (68.0–76.0) 0.519
Gender (male/female) 11/5 41/11 0.502
Physique
    Height (cm) 160 (153–166) 164 (158–169) 0.188
    Body weight (kg) 53.2 (49.2–57.9) 62.0 (52.3–70.3) 0.0765
    Body mass index 21.5 (19.4–24.3) 22.4 (20.0–25.0) 0.311
    Body surface area (DuBois, m2) 1.52 (1.45–1.67) 1.67 (1.54–1.80) 0.0484
Laboratory data
    Aspartate aminotransferase (IU/L) 20.5 (16.5–31.5) 21.0 (18.0–24.0) 0.612
    Alanine aminotransferase (IU/L) 14.0 (11.0–29.0) 14.0 (11.0–20.3) 0.524
    Alkaline phosphatase (IU/L) 247 (211–280) 240 (189–283) 0.608
    Total bilirubin (mg/dL) 0.50 (0.40–0.62) 0.50 (0.40–0.62) 1.00
    γ-glutamyl transpeptidase (IU/L) 28.5 (21.5–63.8) 28.0 (20.0–48.0) 0.573
    Creatinine (mg/dL) 0.80 (0.68–0.90) 0.83 (0.70–0.92) 0.385
    Krebs von den Lungen-6 (U/mL) 920 (694–1356) 1080 (766–1592) 0.800
    Surfactant protein D (ng/dL) 262 (167–440) 309 (188–400) 0.691
Pulmonary function test
    forced vital capacity (L) 1.75 (1.37–2.42) 1.96 (1.65–2.34) 0.457
    %forced vital capacity (%) 64.0 (55.0–71.7) 60.9 (48.9–72.7) 0.822
    %DLCO (%) 51.4 (36.1–60.1) 50.4 (42.2–65.6) 0.464
Six-minute walk test
    lowest SpO2 (%) 81.5 (77.5–87.0) 82.0 (76.0–87.0) 0.922
    walking distance (meter) 378 (281–450) 430 (355–480) 0.299
Concomitant therapy
    Prednisolone (%) 3 (18.8%) 8 (15.4%) 0.712
    Cyclosporine (%) 0 2 (3.8%) 1.00
    Cyclophosphamide (%) 0 2 (3.8%) 1.00
    Tacrolimus (%) 1 (6.2%) 4 (7.7%) 1.00
    Pirfenidone (%) 1 (6.2%) 1 (1.9%) 0.418

Categorical data are presented as numbers (percentages) while continuous data are presented as medians (interquartile ranges). Fisher’s exact test was used to compare categorical data and the Mann-Whitney U test was used to compare continuous data. Abbreviations: DLCO = diffusing capacity for lung carbon monoxide.